BCI
SWTX

Brinker Capital Investments’s SpringWorks Therapeutics SWTX Stock Holding History

Brinker Capital Investments’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-36,222
Closed -$1.6M – 2048
2025
Q1 		$1.6M Buy
36,222
+3,225
+10% +$148K 0.02% 823
2024
Q4 		$1.19M Buy
32,997
+3,058
+10% +$107K 0.01% 954
2024
Q3 		$959K Sell
29,939
-6,064
-17% -$227K 0.01% 1061
2024
Q2 		$1.36M Buy
36,003
+7,125
+25% +$300K 0.01% 834
2024
Q1 		$1.42M Buy
28,878
+7,124
+33% +$329K 0.02% 821
2023
Q4 		$903K Sell
21,754
-6,823
-24% -$178K 0.01% 995
2023
Q3 		$661K Sell
28,577
-614
-2% -$16.8K 0.01% 1090
2023
Q2 		$765K Buy
29,191
+9,711
+50% +$255K 0.01% 1052
2023
Q1 		$501K Buy
19,480
+431
+2% +$12.6K 0.01% 1140
2022
Q4 		$495K Sell
19,049
-431
-2% -$10.6K 0.01% 984
2022
Q3 		$556K Buy
19,480
+4,422
+29% +$127K 0.01% 912
2022
Q2 		$371K Buy
15,058
+31
+0.2% +$1.13K 0.01% 1082
2022
Q1 		$848K Sell
15,027
-6,085
-29% -$348K 0.01% 863
2021
Q4 		$1.31M Buy
+21,112
New +$1.4M 0.02% 720

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Brinker Capital Investments's SWTX Position: Q2 2025 in Review

Brinker Capital Investments sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 36,222 shares — an estimated $1.6M sold.

Brinker Capital Investments first reported a position in SWTX in Q4 2021 and held it in 14 quarters. The position peaked at $1.6M in Q1 2025. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Brinker Capital Investments reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Brinker Capital Investments sold 36,222 SpringWorks Therapeutics shares in Q2 2025, an estimated $1.6M.
  • Brinker Capital Investments first reported a position in SpringWorks Therapeutics in Q4 2021 and held it in 14 quarters.
  • Brinker Capital Investments's SpringWorks Therapeutics position peaked at $1.6M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Brinker Capital Investments's 13F filing for Q2 2025, filed 14 Aug 2025.